Search Results
Results found for "Jana Selent"
- Dr. Antony A. Boucard Jr | Dr. GPCR Ecosystem
biasing latrophilins’ regulation of cyclic AMP pathways and for determining the magnitude of ligand selectivity
- How Lipid Rafts Organize GPCR Signaling | Dr. GPCR Ecosystem
Why This Matters How lipid raft microdomains selectively regulate GPCR signaling and internalization
- Donate to Dr GPCR — Support the GPCR Community & University
. 🎙️ Public Acknowledgment Selected donors are thanked in podcast intros, videos, and events. ⭐ Strategic
- FAQ | Dr. GPCR Ecosystem
Selected recordings may be available afterward through the Dr. GPCR platform.
- YC-VC Insights | Dr. GPCR Ecosystem
experiments to the specific phase and risk tolerance of the asset De-risk Your CRO Strategy I evaluate, select
- Dr. Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
Chris Tate's thermostabilization strategy, which introduced stabilizing mutations selected by thermal The acetate-in-the-buffer discovery 41:47 Thirty years in, and the same speakers keep getting the mic Selected
- Dr. Paul Insel: Unbiased Discovery and the GPCRs We've Been Missing | Dr. GPCR Ecosystem
In principle, biased antagonists could selectively block the disease-relevant pathway. But Dr. changed the direction of a lab 47:30 The future of the GPCR superfamily and the work still to be done Selected
- Dr. Arun Shukla: How Two Arrestins Regulate 800 GPCRs | Dr. GPCR Ecosystem
That selective cross-reactivity turned the reagent into a visual probe of which receptor-arrestin pairs Selected Quotes "There are more than 800 GPCRs, as you know, but there are only two isoforms of beta-arrestins
- Dr. Khaled Abdelrahman, Victoria Rasmussen and Madelyn Moore | Dr. GPCR Ecosystem
He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and
- The Practical Assessment of Signaling Bias | Dr. GPCR Ecosystem
Future of Drug Development 🚀 🔹 By integrating bias into drug design , researchers can craft more selective
- Dr. Roger Sunahara | Dr. GPCR Ecosystem
Our goal is to develop safer beta2AR-selective ligands for the treatment of asthma and acute rescue therapy
- Media Partner Packages | Dr. GPCR Ecosystem
This is real selectivity — a reflection of how seriously we take partner quality and community trust.
- Who We Are | Dr. GPCR Ecosystem
✔ Select news and content ✔ Ecosystem and podcast updates Premium Members Unlock: ✔ Full Weekly News
- Finance is Science too: How Numbers Keep the Lights On with Chuck DeWeese & Joe St. Germain | Dr. GPCR Ecosystem
with Purpose Joe’s personal mission— to make a positive impact on people’s lives —drives their client selection
- University Pricing | Dr. GPCR Ecosystem
Select your situation and we'll show you the best plan. I am a...
- Dr. Graciela Pineyro: Resilience, Lab Life, and the Zoom Effect | Dr. GPCR Ecosystem
self-contained blocks 04:47 The Zoom effect — quieter voices speaking up 05:49 Closing reflections 06:01 Outro Selected
- Dr. Silvio Gutkind: Building a Lab That Doesn't Shut Down | Dr. GPCR Ecosystem
career 12:20 Rotation students as the sorting hat 13:20 When the working hypothesis fails 14:30 Closing Selected
- Lauren Solano: Mapping Careers Beyond the Bench | Dr. GPCR Ecosystem
Selected Quotes "If you had asked me in 2008 if I would be a recruiter slash career coach, I didn't even
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
collaboration with Patrick Sexton and Jim Burch, and the discovery of hybrid molecules with functional selectivity
- Dr. Jennifer Pluznick: Olfactory Receptors in the Kidney and the Gut-Microbe Signal | Dr. GPCR Ecosystem
The aha moment: gut microbes, a GPCR, and blood pressure 39:58 Diversity as everyone's responsibility Selected
- Dr. Terry Hébert | Dr. GPCR Ecosystem
infrastructure breaks down at national scale 10:16 Lessons for the next one, and the shape of the new normal Selected
- Smells Like GPCR Spirit: Cracking Olfactory Codes with Alessandro Nicoli | Dr. GPCR Ecosystem
“Let’s embrace the challenge to study all of them… they’re unique in how they bind ligands, how selective
- Dr. Amynah Pradhan: The Delta Opioid Receptor and the Migraine Paradox | Dr. GPCR Ecosystem
:28 The hidden cost of being the only one in the room 57:05 What the pandemic did to a mouse colony Selected
- Dr. J. Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
Selected Quotes "The very simple concept is that GPCRs do not need to be mutated to be oncogenic."
- Dr. Paul Insel: Rethinking COVID-19 Pathobiology Through GPCR Signaling | Dr. GPCR Ecosystem
Vaccine development speed and public trust 33:40 Staying sane — pickleball, walking, and community Selected
- Jacob Lee and Jin Cho: Rebuilding the Software Layer Under Modern Research | Dr. GPCR Ecosystem
:43 A weekly release cycle built around user feedback 24:13 Why vaccines still take eighteen months Selected
- EARNEST Panel: Can AI Accelerate GPCR Drug Discovery? | Dr. GPCR Ecosystem
Selected Quotes "My computational team told me, 'this receptor is not using arrestin to internalize.
- Dr. Graciela Piñeyro: Partial Agonism, Receptor Recycling, and the Limits of Bias | Dr. GPCR Ecosystem
Selected Quotes "We tried to look for bias and classify our drugs, new and standard drugs, according
- Dr. Joseph Kim: Structural Biology and Drug Discovery at GPCRs | Dr. GPCR Ecosystem
Selected Quotes “The line between drugs and poisons is not so different.”























